• 1. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 4. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 5. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082

Metronidazole-D4 Hydrochloride (CAS No. 1261397-74-3): A Comprehensive Overview

Metronidazole-D4 Hydrochloride (CAS No. 1261397-74-3) is a deuterated derivative of the widely used antimicrobial and antiprotozoal agent, metronidazole. This compound is particularly valuable in pharmaceutical research and development, especially in the context of drug metabolism studies and pharmacokinetic evaluations. The deuterium substitution in Metronidazole-D4 Hydrochloride provides enhanced stability and distinct isotopic labeling, making it an essential tool for scientists and researchers.

Chemical Structure and Properties: Metronidazole-D4 Hydrochloride has the molecular formula C₆H₈D₄N₃O₂·HCl, with a molecular weight of approximately 208.7 g/mol. The compound is a white to off-white crystalline powder that is highly soluble in water and ethanol. The deuterium atoms are strategically placed to minimize metabolic degradation, thereby extending the half-life of the molecule in biological systems. This property is crucial for studying the pharmacokinetics and metabolism of metronidazole in vivo.

Mechanism of Action: Like its non-deuterated counterpart, Metronidazole-D4 Hydrochloride exerts its antimicrobial effects by targeting anaerobic bacteria and certain protozoa. The mechanism involves the reduction of the nitro group by bacterial enzymes, leading to the formation of reactive intermediates that damage bacterial DNA. This results in cell death and effectively eliminates the pathogen. The deuterium substitution does not alter this mechanism but provides a more stable molecule for detailed mechanistic studies.

Clinical Applications and Research: Metronidazole-D4 Hydrochloride is primarily used as a research tool to investigate the pharmacokinetics and metabolism of metronidazole. Recent studies have highlighted its utility in understanding drug interactions and optimizing dosing regimens. For instance, a 2021 study published in the Journal of Pharmaceutical Sciences demonstrated that Metronidazole-D4 Hydrochloride can be used to evaluate the impact of food on the absorption and distribution of metronidazole, providing valuable insights for clinical dosing strategies.

Safety and Toxicology: While Metronidazole-D4 Hydrochloride shares many safety profiles with metronidazole, it is important to note that deuterated compounds can have different pharmacological properties. Preclinical studies have shown that Metronidazole-D4 Hydrochloride exhibits low toxicity at therapeutic concentrations. However, as with any pharmaceutical compound, it should be handled with care, and appropriate safety measures should be followed during laboratory use.

Analytical Methods: The accurate quantification of Metronidazole-D4 Hydrochloride in biological matrices is crucial for pharmacokinetic studies. High-performance liquid chromatography (HPLC) coupled with mass spectrometry (LC-MS/MS) is commonly used for this purpose due to its high sensitivity and specificity. A recent method developed by researchers at the University of California demonstrated improved detection limits and faster analysis times, making it an ideal choice for routine laboratory use.

FUTURE DIRECTIONS AND CONCLUSIONS: The development of deuterated compounds like Metronidazole-D4 Hydrochloride represents a significant advancement in pharmaceutical research. These compounds offer unique advantages in terms of stability and isotopic labeling, enabling more precise and detailed studies of drug metabolism and pharmacokinetics. As research continues to evolve, it is likely that we will see increased applications of deuterated compounds in both preclinical and clinical settings.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)